324 related articles for article (PubMed ID: 15209517)
1. Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils.
Waller A; Sutton KL; Kinzer-Ursem TL; Absood A; Traynor JR; Linderman JJ; Omann GM
Biochemistry; 2004 Jun; 43(25):8204-16. PubMed ID: 15209517
[TBL] [Abstract][Full Text] [Related]
2. Multiple receptor states are required to describe both kinetic binding and activation of neutrophils via N-formyl peptide receptor ligands.
Kinzer-Ursem TL; Sutton KL; Waller A; Omann GM; Linderman JJ
Cell Signal; 2006 Oct; 18(10):1732-47. PubMed ID: 16530386
[TBL] [Abstract][Full Text] [Related]
3. A mathematical model for ligand/receptor/G-protein dynamics and actin polymerization in human neutrophils.
Adams JA; Omann GM; Linderman JJ
J Theor Biol; 1998 Aug; 193(4):543-60. PubMed ID: 9745752
[TBL] [Abstract][Full Text] [Related]
4. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
Posner RG; Fay SP; Domalewski MD; Sklar LA
Mol Pharmacol; 1994 Jan; 45(1):65-73. PubMed ID: 8302282
[TBL] [Abstract][Full Text] [Related]
5. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
6. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
7. Fixation traps formyl peptide receptors in high and low affinity forms that can be regulated by GTP[S] in the absence of ligand.
Domalewski MD; Guyer DA; Freer RJ; Muthukumaraswamy N; Sklar LA
J Recept Signal Transduct Res; 1996; 16(1-2):59-75. PubMed ID: 8771531
[TBL] [Abstract][Full Text] [Related]
8. Subsecond modulation of formyl peptide-linked guanine nucleotide-binding proteins by guanosine 5'-O-(3-thio)triphosphate in permeabilized neutrophils.
Neubig RR; Sklar LA
Mol Pharmacol; 1993 May; 43(5):734-40. PubMed ID: 8502230
[TBL] [Abstract][Full Text] [Related]
9. Ligand/receptor internalization: a spectroscopic analysis and a comparison of ligand binding, cellular response, and internalization by human neutrophils.
Sklar LA; Jesaitis AJ; Painter RG; Cochrane CG
J Cell Biochem; 1982; 20(2):193-202. PubMed ID: 6302116
[TBL] [Abstract][Full Text] [Related]
10. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.
Ye RD; Quehenberger O; Thomas KM; Navarro J; Cavanagh SL; Prossnitz ER; Cochrane CG
J Immunol; 1993 Feb; 150(4):1383-94. PubMed ID: 8432984
[TBL] [Abstract][Full Text] [Related]
11. Competitive binding kinetics in ligand-receptor-competitor systems. Rate parameters for unlabeled ligands for the formyl peptide receptor.
Sklar LA; Sayre J; McNeil VM; Finney DA
Mol Pharmacol; 1985 Oct; 28(4):323-30. PubMed ID: 4058418
[TBL] [Abstract][Full Text] [Related]
12. Strategies for positioning fluorescent probes and crosslinkers on formyl peptide ligands.
Vilven JC; Domalewski M; Prossnitz ER; Ye RD; Muthukumaraswamy N; Harris RB; Freer RJ; Sklar LA
J Recept Signal Transduct Res; 1998; 18(2-3):187-221. PubMed ID: 9651885
[TBL] [Abstract][Full Text] [Related]
13. A novel nonpeptide ligand for formyl peptide receptor-like 1.
Nanamori M; Cheng X; Mei J; Sang H; Xuan Y; Zhou C; Wang MW; Ye RD
Mol Pharmacol; 2004 Nov; 66(5):1213-22. PubMed ID: 15308762
[TBL] [Abstract][Full Text] [Related]
14. Significance of the extracellular domain and the carbohydrates of the human neutrophil N-formyl peptide chemotactic receptor for the signal transduction by the receptor.
Remes JJ; Petäjä-Repo UE; Tuukkanen KJ; Rajaniemi HJ
Exp Cell Res; 1993 Nov; 209(1):26-32. PubMed ID: 8224002
[TBL] [Abstract][Full Text] [Related]
15. The uncoupled state of the human formyl peptide receptor.
Gilbert TL; Prossnitz ER; Sklar LA
J Recept Signal Transduct Res; 1999; 19(1-4):327-40. PubMed ID: 10071768
[TBL] [Abstract][Full Text] [Related]
16. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
[TBL] [Abstract][Full Text] [Related]
17. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
[TBL] [Abstract][Full Text] [Related]
18. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
Dentino AR; Raj PA; De Nardin E
Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
[TBL] [Abstract][Full Text] [Related]
19. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
[TBL] [Abstract][Full Text] [Related]
20. N-Formyl peptide receptor subtypes in human neutrophils activate L-plastin phosphorylation through different signal transduction intermediates.
Paclet MH; Davis C; Kotsonis P; Godovac-Zimmermann J; Segal AW; Dekker LV
Biochem J; 2004 Jan; 377(Pt 2):469-77. PubMed ID: 14556648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
